Zhuo-yuan Lin

Guangdong Key Laboratory Of Clinical Molecular
Guangzhou, 510180, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.

Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.

Journal: Molecular cancer

Published: March 21, 2023

Dietary magnesium is able to influence the relationship between vitamin C and estimated glomerular filtration rate: A cross-sectional study.

Dietary magnesium is able to influence the relationship between vitamin C and estimated glomerular filtration rate: A cross-sectional study.

Journal: Food science & nutrition

Published: January 07, 2023

Tumor Suppressor Role and Clinical Significance of the FEV Gene in Prostate Cancer.

Tumor Suppressor Role and Clinical Significance of the FEV Gene in Prostate Cancer.

Journal: Disease markers

Published: May 06, 2021

Circ_KATNAL1 regulates prostate cancer cell growth and invasiveness through the miR-145-3p/WISP1 pathway.

Circ_KATNAL1 regulates prostate cancer cell growth and invasiveness through the miR-145-3p/WISP1 pathway.

Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire

Published: December 05, 2019

ARNT-dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer.

ARNT-dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer.

Journal: Molecular carcinogenesis

Published: August 21, 2019

Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.

Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.

Journal: Molecular cancer

Published: August 08, 2019

Extracellular vesicle-derived circ_SLC19A1 promotes prostate cancer cell growth and invasion through the miR-497/septin 2 pathway.

Extracellular vesicle-derived circ_SLC19A1 promotes prostate cancer cell growth and invasion through the miR-497/septin 2 pathway.

Journal: Cell biology international

Published: July 28, 2019

TRIB1 induces macrophages to M2 phenotype by inhibiting IKB-zeta in prostate cancer.

TRIB1 induces macrophages to M2 phenotype by inhibiting IKB-zeta in prostate cancer.

Journal: Cellular signalling

Published: January 01, 2019

MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.

MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.

Journal: Molecular cancer

Published: December 01, 2016

Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer.

Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer.

Journal: OncoTargets and therapy

Published: May 05, 2016

E2F1 promotes tumor cell invasion and migration through regulating CD147 in prostate cancer.

E2F1 promotes tumor cell invasion and migration through regulating CD147 in prostate cancer.

Journal: International journal of oncology

Published: October 06, 2015

Overexpression of PDZ-binding kinase confers malignant phenotype in prostate cancer via the regulation of E2F1.

Overexpression of PDZ-binding kinase confers malignant phenotype in prostate cancer via the regulation of E2F1.

Journal: International journal of biological macromolecules

Published: February 11, 2015

Showing 1-12 of 20

Last Updated: 09/26/2026